Corin signed a binding agreement to acquire Global Orthopaedic Technology (GOT), manufacturer of hip and knee replacement devices in Australia. The activity lends significant scale to Corin’s operations in the region, where its R&D Hub is located.
GOT was established in 1999 and serves Australia and the U.S. The company has formed numerous alliances for use of enabling robotics and navigation, such as Materialise Patient Specific Instrumentation for its Apex Knee and exclusive use of Optimized Ortho knee simulation technology in Australia. Through other partnerships, GOT also distributes biologics from Artoss and Kyeron.
U.K.-based Corin was founded in 1985. The company markets hip and knee replacement devices and complementary technologies in Australia, France, Japan, the U.K. and the U.S. In 2Q18, Corin was purchased by a Permira funds-backed company. For 2017, ORTHOWORLD estimated Corin’s revenue between US $120MM to $130MM.
Corin signed a binding agreement to acquire Global Orthopaedic Technology (GOT), manufacturer of hip and knee replacement devices in Australia. The activity lends significant scale to Corin's operations in the region, where its R&D Hub is located.
GOT was established in 1999 and serves Australia and the U.S. The company has formed numerous...
Corin signed a binding agreement to acquire Global Orthopaedic Technology (GOT), manufacturer of hip and knee replacement devices in Australia. The activity lends significant scale to Corin’s operations in the region, where its R&D Hub is located.
GOT was established in 1999 and serves Australia and the U.S. The company has formed numerous alliances for use of enabling robotics and navigation, such as Materialise Patient Specific Instrumentation for its Apex Knee and exclusive use of Optimized Ortho knee simulation technology in Australia. Through other partnerships, GOT also distributes biologics from Artoss and Kyeron.
U.K.-based Corin was founded in 1985. The company markets hip and knee replacement devices and complementary technologies in Australia, France, Japan, the U.K. and the U.S. In 2Q18, Corin was purchased by a Permira funds-backed company. For 2017, ORTHOWORLD estimated Corin’s revenue between US $120MM to $130MM.
Copy to clipboard 
